Delays are not uncommon.
I’ve been waiting since 2016 for a pivotal results trial to be forfilled. An extra month or so is not an issue.
A well run site that sticks to protocols is the key and the data collation is solid. I think we are in safe hands.
In the last year before pivotal results, I feel that it’s at the ‘top of the straight’ to the commercial finish line.
And @vintage, I couldn’t agree with you more
cheers
Ann: Dimerix presentation at Bioshares Biotech Summit, page-52
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
0.010(1.96%) |
Mkt cap ! $275.1M | |||
| Open | High | Low | Value | Volume |
| 51.0¢ | 52.0¢ | 49.5¢ | $687.4K | 1.363M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 43233 | 51.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 19771 | 6 |
View Market Depth
| Last trade - 12.02pm 17/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |